Project Grant K99EY036489

Award Date 9/30/24
Completion Date 8/31/26
Dollars Obligated $117K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
This Project Grant award, valued at $132,597.00 and provided by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), supports research aimed at improving retinal ganglion cell (RGC) replacement therapies for glaucoma. The research project, conducted by The Schepens Eye Research Institute, Inc., a non-profit organization in Boston, Massachusetts, focuses on investigating the role of neural activity in regulating the integration of transplanted RGCs within the host...
This Project Grant award from the National Eye Institute (NEI), under its Vision Research program (CFDA 93.867), supports research to evaluate the functional impact of retinal ganglion cell (RGC) loss during the progression of neurofibromatosis type-1 (NF1) and the potential of RGC transplantation to integrate with the remaining retinal circuitry. The $357,056 award, effective January 1, 2025 through December 31, 2026, will be conducted at Stanford University. The research aims to develop...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), will fund research at the University of California, San Francisco (UCSF) to study the neural mechanisms of sensory encoding after photoreceptor degeneration. The $237,588 award, effective June 1, 2025 through December 31, 2027, will leverage the vertical optokinetic reflex, a visual behavior that tracks global motion, to investigate how cone degeneration disrupts noise...
This Project Grant award from the National Eye Institute (NEI), part of the U.S. Department of Health and Human Services, under the Vision Research (CFDA 93.867) program, provides $500,500 to support research on the role of retinal ganglion cells in shaping the identity and function of neurons in the superior colliculus visual processing region. The key objectives are to: 1) determine how retinal input influences the morphology and transcriptional profiles of genetically-defined neuron...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), will support research to investigate the molecular, cellular, and transcriptional mechanisms that regulate reactive astrocyte function in the optic nerve head and retina. The research aims to discover new biological pathways that control glial reactivity, with the goal of developing gliotherapeutics for the treatment of glaucoma and other optic neuropathies. The $2,260,440 award...
This Project Grant award, provided by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867), supports research to understand how the retina adapts to photoreceptor loss in retinal degeneration. The $624,230 award to the University of California, Los Angeles (UCLA) spans May 1, 2025 to April 30, 2029. The research aims to document changes in rod photoreceptor function and connectivity as degeneration progresses, as well as investigate plasticity in retinal...
This Project Grant award, ID R01EY036880, was provided by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) to support research on the role of optic nerve head astrocytes in the development of glaucomatous optic nerve damage. The total funding amount is $387,428, awarded from March 1, 2025 through February 28, 2030. The research aims to investigate how transient biomechanical strains on the optic nerve head prime astrocytes to develop greater dysfunction, including...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), aims to develop a novel, non-invasive, and sensitive diagnostic method for measuring retinal dysfunction. The $491,466 award, effective January 1, 2025 through December 31, 2026, will support research to expand the use of a visually-evoked compensatory behavior called the optokinetic reflex (OKR) for the detection and monitoring of localized cone and inner retinal...
The National Eye Institute (NEI) awarded a Project Grant under the Vision Research program (CFDA 93.867) to the University of Washington to study how the retina encodes visual information in natural environments with dynamic changes in light intensity. The $487,862 award, effective September 1, 2024 through May 31, 2029, will support three research aims: 1) determining the role of photoreceptor adaptation in shaping retinal ganglion cell (RGC) responses, 2) probing the contribution of RGC...
This $460,625 Project Grant was awarded by the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) to Yale University. The grant will fund research to investigate the cellular and synaptic mechanisms underlying changes in retinal ganglion cell (RGC) activity following optic nerve injuries in mouse models of glaucoma. Specifically, the project aims to (1) determine the underlying mechanisms for altered RGC activity after increased intraocular pressure or...

This federal Project Grant award, with identification number K99EY036489, was provided by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867). The $116,888 award is funding research to study how retinal ganglion cells (RGCs) interact with nearby non-neuronal cells, such as vascular endothelial cells, to modulate visual signal processing. The primary goals are to investigate how mechanosensitive channels like Piezo2 affect the light response of perivascular RGCs, and to explore the neuroprotective role of these perivascular RGCs in retinal diseases. The award supports research to be conducted at the University of California, San Francisco from September 30, 2024 to August 31, 2026. The findings from this study may uncover novel neurovascular protective mechanisms and lead to new treatment strategies for vision-related disorders.

Generated 7/1/25, 4:32 AM